1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Associated With Epidermal Growth Factor Receptor InhibitorsInfections, Skin and Connective Tissue Diseases, nail disorder, paronychia, skin disorder, skin disorder caused by infectionRecruitingPhase 22026-03-31NCT05639933